De Geest K - Search Results

1

A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Gold MA, Brady WE, Lankes HA, Rose PG, Kelley JL, De Geest K, Crispens MA, Resnick KE, Howell SB. Gold MA, et al. Among authors: de geest k. Gynecol Oncol. 2012 Jun;125(3):635-9. doi: 10.1016/j.ygyno.2012.03.023. Epub 2012 Mar 22. Gynecol Oncol. 2012. PMID: 22446624 Free PMC article. Clinical Trial.

2

5-fluorouracil and low-dose leucovorin in the treatment of recurrent epithelial ovarian carcinoma. A phase II trial of the Gynecologic Oncology Group.

Look KY, Blessing JA, Muss HB, DeGeest K. Look KY, et al. Am J Clin Oncol. 1992 Dec;15(6):494-6. doi: 10.1097/00000421-199212000-00006. Am J Clin Oncol. 1992. PMID: 1449111 Clinical Trial.

3

Survival of patients with ovarian epithelial carcinomas after second-look laparotomy.

Podczaski E, Manetta A, Kaminski P, Ricelli A, Larson J, DeGeest K, Mortel R. Podczaski E, et al. Gynecol Oncol. 1990 Jan;36(1):43-7. doi: 10.1016/0090-8258(90)90106-u. Gynecol Oncol. 1990. PMID: 2295451

4

Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group study.

Berek JS, Markman M, Stonebraker B, Lentz SS, Adelson MD, DeGeest K, Moore D. Berek JS, et al. Gynecol Oncol. 1999 Oct;75(1):10-4. doi: 10.1006/gyno.1999.5532. Gynecol Oncol. 1999. PMID: 10502418 Clinical Trial.

5

Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trial.

Markman M, Blessing JA, DeGeest K, Morgan M, Look KY, Herzog TJ, Rose PG. Markman M, et al. Gynecol Oncol. 1999 Dec;75(3):444-6. doi: 10.1006/gyno.1999.5640. Gynecol Oncol. 1999. PMID: 10600304 Clinical Trial.

6

Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study.

Curtin JP, Blessing JA, Soper JT, DeGeest K. Curtin JP, et al. Gynecol Oncol. 2001 Nov;83(2):268-70. doi: 10.1006/gyno.2001.6256. Gynecol Oncol. 2001. PMID: 11606082 Clinical Trial.

7

Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.

Zaino R, Whitney C, Brady MF, DeGeest K, Burger RA, Buller RE. Zaino R, et al. Gynecol Oncol. 2001 Nov;83(2):355-62. doi: 10.1006/gyno.2001.6400. Gynecol Oncol. 2001. PMID: 11606097

8

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study.

Rose PG, Blessing JA, Ball HG, Hoffman J, Warshal D, DeGeest K, Moore DH. Rose PG, et al. Gynecol Oncol. 2003 Feb;88(2):130-5. doi: 10.1016/s0090-8258(02)00091-4. Gynecol Oncol. 2003. PMID: 12586591 Clinical Trial.

9

Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study.

Tate Thigpen J, Blessing JA, DeGeest K, Look KY, Homesley HD; Gynecologic Oncology Group. Tate Thigpen J, et al. Gynecol Oncol. 2004 May;93(2):336-9. doi: 10.1016/j.ygyno.2004.01.007. Gynecol Oncol. 2004. PMID: 15099942 Clinical Trial.

10

Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.

Greer BE, Bundy BN, Ozols RF, Fowler JM, Clarke-Pearson D, Burger RA, Mannel R, DeGeest K, Hartenbach EM, Baergen RN, Copeland LJ. Greer BE, et al. Gynecol Oncol. 2005 Oct;99(1):71-9. doi: 10.1016/j.ygyno.2005.05.012. Gynecol Oncol. 2005. PMID: 16039699 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters